# Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain

> **NCT01278225** · — · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 80 (estimated)

## Conditions studied

- Pain
- Peripheral Neuropathy

## Interventions

- **BEHAVIORAL:** EEG biofeedback (BF) Group
- **BEHAVIORAL:** Wait-List Control (WLC) Group
- **BEHAVIORAL:** Follow UP Questionnaires

## Key facts

- **NCT ID:** NCT01278225
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-02
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01278225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01278225, "Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01278225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*